Period Blood Research Gains Momentum, Offering Potential Breakthroughs in women’s Health
BOSTON, MA – A surge of scientific interest is focusing on a previously untapped resource in women’s health: menstrual blood. Researchers are exploring its potential to revolutionize diagnostics and treatments for conditions like endometriosis, fueled by recent initiatives and growing investment, despite ongoing funding challenges.
For decades, menstrual blood has been largely dismissed as a biological waste product. Though, scientists are now recognizing it as a rich source of biomarkers and cells offering unique insights into a woman’s health. Researchers envision a future where period blood analysis provides early detection of diseases, personalized drug testing, and even the creation of “organoids”-miniature, patient-specific models of the uterine lining-to study conditions like endometriosis. This emerging field could dramatically improve the lives of the millions of women worldwide affected by gynecological conditions, many of whom face lengthy diagnostic delays and limited treatment options.
Dr. Christine Gargett, a researcher at the University of Cambridge, is pioneering the advancement of a “menstrual fluid biobank” to store endometrial tissue fragments from period blood. her goal is to grow personalized organoids for women with endometriosis, allowing doctors to test drug responses tailored to each individual.”Blokes cringe if you talk about it in the pub,” Gargett says. “[But] menstrual fluid has so much potential.”
several companies are already working to unlock this potential. NGJ and Qvin, both Bay Area-based startups, have secured approximately $20 million in funding each over the past decade to develop period blood-based diagnostic tests. Though, researchers emphasize that this investment remains modest compared to the vast resources available in Silicon Valley. Currently, projects like the development of an improved menstrual cup by The Rose project and Burns’ endometriosis test are stalled due to lack of funding.
A significant boost arrived earlier this year with the launch of a $10 million menstruation science initiative at the Massachusetts Institute of Technology (MIT). ”This is frontier science,” says Linda Griffith,director of MIT’s center for gynaepathology research and the initiative’s leader.
NGJ CEO Tariyal underscores the need for continued research and participation, stating, “If you’re thinking about how you can contribute, give us your tampon.” The growing momentum suggests that period blood may indeed become a critical component of the future of women’s healthcare.
